123 related articles for article (PubMed ID: 26433710)
1. Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.
Guffroy A; Dima A; Nespola B; Poindron V; Sibilia J; Herbrecht R; De Sèze J; Habersetzer F; Andres E; Quoix E; Ohlmann P; Cribier B; Langer B; Martin T; Pasquali JL; Goetz J; Korganow AS
Joint Bone Spine; 2016 May; 83(3):330-4. PubMed ID: 26433710
[TBL] [Abstract][Full Text] [Related]
2. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods.
Mahler M; Silverman ED; Fritzler MJ
Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252
[TBL] [Abstract][Full Text] [Related]
3. Glyceraldehyde 3-phosphate dehydrogenase is a novel autoantigen leading autoimmune responses to proliferating cell nuclear antigen multiprotein complexes in lupus patients.
Takasaki Y; Kaneda K; Matsushita M; Yamada H; Nawata M; Matsudaira R; Asano M; Mineki R; Shindo N; Hashimoto H
Int Immunol; 2004 Sep; 16(9):1295-304. PubMed ID: 15262899
[TBL] [Abstract][Full Text] [Related]
4. Identification of an autoantibody against the proliferating cell nuclear antigen from a patient with systemic lupus erythematosus.
Hsu TC; Lan JL; Kao SH; Li SL; Liu YC; Huang CY; Tzang BS
Chin J Physiol; 2010 Feb; 53(1):11-8. PubMed ID: 21789880
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA).
Mahler M; Miyachi K; Peebles C; Fritzler MJ
Autoimmun Rev; 2012 Aug; 11(10):771-5. PubMed ID: 22381917
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
[TBL] [Abstract][Full Text] [Related]
8. Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.
Tzang BS; Chen TY; Hsu TC; Liu YC; Tsay GJ
Ann Rheum Dis; 1999 Oct; 58(10):630-4. PubMed ID: 10491362
[TBL] [Abstract][Full Text] [Related]
9. [Anti-PCNA antibody].
Yamanaka K; Takasaki Y
Rinsho Byori; 1993 Aug; 41(8):888-96. PubMed ID: 8103808
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody to proliferating cell nuclear antigen (PCNA) in SLE: a clinical and serological study.
Asero R; Origgi L; Crespi S; Bertetti E; D'Agostino P; Riboldi P
Clin Exp Rheumatol; 1987; 5(3):241-6. PubMed ID: 2892602
[TBL] [Abstract][Full Text] [Related]
11. Serological profile and clinical features of nucleolar antinuclear pattern in patients with systemic lupus erythematosus from southwestern Spain.
Cabrera CM; Fernández-Grande E; Urra JM
Lupus; 2016 Aug; 25(9):980-7. PubMed ID: 26846693
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
13. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
[TBL] [Abstract][Full Text] [Related]
14. [Anti-PCNA antibody].
Takasaki Y
Nihon Rinsho; 1999 Nov; 57 Suppl():456-8. PubMed ID: 10635882
[No Abstract] [Full Text] [Related]
15. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases.
Kaneda K; Takasaki Y; Takeuchi K; Yamada H; Nawata M; Matsushita M; Matsudaira R; Ikeda K; Yamanaka K; Hashimoto H
J Rheumatol; 2004 Nov; 31(11):2142-50. PubMed ID: 15517625
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation.
Takasaki Y; Kogure T; Takeuchi K; Kaneda K; Yano T; Hirokawa K; Hirose S; Shirai T; Hashimoto H
J Immunol; 2001 Apr; 166(7):4780-7. PubMed ID: 11254741
[TBL] [Abstract][Full Text] [Related]
17. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients.
Murashima A; Takasaki Y; Ohgaki M; Hashimoto H; Shirai T; Hirose S
J Clin Immunol; 1990 Jan; 10(1):28-37. PubMed ID: 1968905
[TBL] [Abstract][Full Text] [Related]
18. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to nonhistone nuclear antigens and their clinical significance.
Nakamura RM; Tan EM
Hum Pathol; 1983 May; 14(5):392-400. PubMed ID: 6341205
[TBL] [Abstract][Full Text] [Related]
20. Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues.
Chan PK; Frakes R; Tan EM; Brattain MG; Smetana K; Busch H
Cancer Res; 1983 Aug; 43(8):3770-7. PubMed ID: 6134581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
